Santiago Ferro
Hoofd Techniek/Wetenschap/O&O bij CORE ONE LABS INC.
Vermogen: 61 749 $ op 31-05-2024
Profiel
Santiago Ferro currently works at Akome Biotech Ltd., as Chief Executive Officer and Core One Labs, Inc., as Chief Medical Officer & Director.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CORE ONE LABS, INC.
0.89% | 29-01-2024 | 417 225 ( 0.89% ) | 61 749 $ | 31-05-2024 |
Actieve functies van Santiago Ferro
| Bedrijven | Functie | Begin |
|---|---|---|
| CORE ONE LABS INC. | Hoofd Techniek/Wetenschap/O&O | 05-05-2021 |
Akome Biotech Ltd.
 Akome Biotech Ltd. Pharmaceuticals: MajorHealth Technology Part of Core One Labs, Inc., Akome Biotech Ltd. is a Canadian company that manufactures psychedelic-based pharmaceutical products. The company was founded by Fadia Saad. The CEO is Santiago Ferro. Akome Biotech was acquired by Core One Labs, Inc. on May 04, 2021 for $2.27 million. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CORE ONE LABS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Akome Biotech Ltd.
Akome Biotech Ltd. Pharmaceuticals: MajorHealth Technology Part of Core One Labs, Inc., Akome Biotech Ltd. is a Canadian company that manufactures psychedelic-based pharmaceutical products. The company was founded by Fadia Saad. The CEO is Santiago Ferro. Akome Biotech was acquired by Core One Labs, Inc. on May 04, 2021 for $2.27 million. | Health Technology |
